Adaptive optics monitors photoreceptor response to therapy in multifocal choroiditis

Recently published in Retinal Cases & Brief Reports, a longitudinal case study describes the course of retinal alterations…

Imagine Eyes to meet pharmas to speed up the development of therapies

To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…

Replay available – Webinar on AO imaging in AMD

Interview & discussion with 3 ophthalmology professors about the use of AO retinal imaging in dry AMD.

Retinal adaptive optics imaging goes multimodal

A publication in Nature Scientific Reports introduces a technology that delivers multimodal multiscale retinal images, developed by MERLIN - a collaborative project uniting Imagine Eyes, 3 academic teams and 2 clinical centers. It received financial support from the European Commission's Horizon 2020 program.

Great presentations at the rtx1 users’ e-symposium 2022! Replay available

Last week, we had the pleasure to host the rtx1 users’ e-symposium 2022, chaired by Prof. Paulo E. Stanga from The Retina Clinic London, and Dr. Daniela Bacherini from AOU Careggi Teaching Hospital in Florence.

Adaptive optics reveals undetected microcysts in retinal neurodegeneration

In a study in autosomal-dominant optic atrophy (ADOA), conducted at the University of Copenhagen - Rigshospitalet and the…

Imagine Eyes laureate of NEXT French Healthcare

We are happy to share that Imagine Eyes has been selected for NEXT French Healthcare, an acceleration program dedicated…

ARVO 2022 – New retinal findings with Imagine Eyes’ AO imaging

At ARVO 2022, users of Imagine Eyes’ adaptive optics (AO) imaging systems will present new clinical findings in several retinal diseases, myopia, as well as multiple sclerosis. They will report on cellular phenotypes, structure-function relations, and surgical outcomes assessed at the cellular level.

New technique detects small drusen in AMD

In a joint study in age-related macular degeneration (AMD), clinical researchers at the University of Pittsburgh, USA, and…

Study compares AO and OCT biomarkers of rod-cone dystrophy progression

A longitudinal cohort study in rod-cone dystrophy (RCD) conducted by clinical researchers at the Lions Eye Institute in Perth,…